Elucid
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
Business Model:
Revenue: $100M
Employees: 51-200
Industries / Tags:
Detailed Elucid Information
Geographic Data
Address: 2 Park Plaza
City: Boston
State: MA
Zip: 02116
Country: US
Financial Info
Stage:
series b
Raised Last:
$27M
Raised Total:$27M
Social
Metrics
4,706,740Website Global Rank
1,867Website Monthly Traffic
Twitter Followers
Description
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, &a; cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid&s;s main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) &a; treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.
Contact Phone:
+16173299487
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
